158 related articles for article (PubMed ID: 35572572)
1. Low Intestinal IL22 Associates With Increased Transplant-Related Mortality After Allogeneic Stem Cell Transplantation.
Ghimire S; Ederer KU; Meedt E; Weber D; Matos C; Hiergeist A; Zeman F; Wolff D; Edinger M; Poeck H; Herr W; Gessner A; Holler E; Bülow S
Front Immunol; 2022; 13():857400. PubMed ID: 35572572
[TBL] [Abstract][Full Text] [Related]
2. GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum Antibiotics.
Ghimire S; Weber D; Hippe K; Meedt E; Hoepting M; Kattner AS; Hiergeist A; Gessner A; Matos C; Ghimire S; Wolff D; Edinger M; Hoffmann P; Poeck H; Herr W; Holler E
Front Immunol; 2021; 12():753287. PubMed ID: 34777363
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of the vitamin D receptor expression during acute gastrointestinal graft versus host disease is associated with poor outcome after allogeneic stem cell transplantation.
Matos C; Mamilos A; Shah PN; Meedt E; Weber D; Ghimire S; Hiergeist A; Gessner A; Dickinson A; Dressel R; Walter L; Stark K; Heid IM; Poeck H; Edinger M; Wolff D; Herr W; Holler E; Kreutz M; Ghimire S
Front Immunol; 2022; 13():1028850. PubMed ID: 36341397
[TBL] [Abstract][Full Text] [Related]
5. Restrictive Versus Permissive Use of Broad-spectrum Antibiotics in Patients Receiving Allogeneic Stem Cell Transplantation and With Early Fever Due to Cytokine Release Syndrome: Evidence for Beneficial Microbiota Protection Without Increase in Infectious Complications.
Weber D; Hiergeist A; Weber M; Ghimire S; Salzberger B; Wolff D; Poeck H; Gessner A; Edinger M; Herr W; Meedt E; Holler E
Clin Infect Dis; 2023 Nov; 77(10):1432-1439. PubMed ID: 37386935
[TBL] [Abstract][Full Text] [Related]
6. Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation.
Weber D; Jenq RR; Peled JU; Taur Y; Hiergeist A; Koestler J; Dettmer K; Weber M; Wolff D; Hahn J; Pamer EG; Herr W; Gessner A; Oefner PJ; van den Brink MRM; Holler E
Biol Blood Marrow Transplant; 2017 May; 23(5):845-852. PubMed ID: 28232086
[TBL] [Abstract][Full Text] [Related]
7. The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease.
Svenberg P; Wang T; Uhlin M; Watz E; Remberger M; Ringden O; Mattsson J; Uzunel M
Clin Transplant; 2019 Jun; 33(6):e13537. PubMed ID: 30873642
[TBL] [Abstract][Full Text] [Related]
8. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
Shono Y
Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
[TBL] [Abstract][Full Text] [Related]
9. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
Modi A; Rybicki L; Majhail NS; Mossad SB
Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
11. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease.
Holler E; Butzhammer P; Schmid K; Hundsrucker C; Koestler J; Peter K; Zhu W; Sporrer D; Hehlgans T; Kreutz M; Holler B; Wolff D; Edinger M; Andreesen R; Levine JE; Ferrara JL; Gessner A; Spang R; Oefner PJ
Biol Blood Marrow Transplant; 2014 May; 20(5):640-5. PubMed ID: 24492144
[TBL] [Abstract][Full Text] [Related]
12. Intestinal IgA-positive plasma cells are highly sensitive indicators of alloreaction early after allogeneic transplantation and associate with both graft-versus-host disease and relapse-related mortality.
Scheidler L; Hippe K; Ghimire S; Weber D; Weber M; Meedt E; Hoffmann P; Lehn P; Burkhardt R; Mamilos A; Edinger M; Wolff D; Poeck H; Evert M; Gessner A; Herr W; Holler E
Haematologica; 2023 Nov; 108(11):2993-3000. PubMed ID: 37259539
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 polymorphisms: influence on transplant-related mortality and survival in children undergoing allogeneic hematopoietic stem cell transplantation.
Hammrich J; Wittig S; Ernst T; Gruhn B
J Cancer Res Clin Oncol; 2018 Mar; 144(3):587-592. PubMed ID: 29335768
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Antibiotic-Mediated Modification of the Intestinal Microbiome on Outcomes of Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-Analysis.
Gavriilaki M; Sakellari I; Anagnostopoulos A; Gavriilaki E
Biol Blood Marrow Transplant; 2020 Sep; 26(9):1738-1746. PubMed ID: 32447043
[TBL] [Abstract][Full Text] [Related]
15. The association between the incidence of intestinal graft-vs-host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation.
Hidaka D; Hayase E; Shiratori S; Hasegawa Y; Ishio T; Tateno T; Okada K; Goto H; Sugita J; Onozawa M; Nakagawa M; Kahata K; Endo T; Hashimoto D; Teshima T
Clin Transplant; 2018 Sep; 32(9):e13361. PubMed ID: 30054935
[TBL] [Abstract][Full Text] [Related]
16. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide.
Greco R; Lorentino F; Nitti R; Lupo Stanghellini MT; Giglio F; Clerici D; Xue E; Lazzari L; Piemontese S; Mastaglio S; Assanelli A; Marktel S; Corti C; Bernardi M; Ciceri F; Peccatori J
Front Immunol; 2019; 10():2319. PubMed ID: 31632401
[No Abstract] [Full Text] [Related]
18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
19. Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use.
Weber D; Weber M; Meedt E; Ghimire S; Wolff D; Edinger M; Poeck H; Hiergeist A; Gessner A; Ayuk F; Roesler W; Wölfl M; Kraus S; Zeiser R; Bertrand H; Bader P; Ullrich E; Eder M; Gleich S; Young R; Herr W; Levine JE; Ferrara JLM; Holler E
Blood Adv; 2023 Apr; 7(7):1326-1335. PubMed ID: 36350750
[TBL] [Abstract][Full Text] [Related]
20. Prolonged Suppression of Butyrate-Producing Bacteria Is Associated With Acute Gastrointestinal Graft-vs-Host Disease and Transplantation-Related Mortality After Allogeneic Stem Cell Transplantation.
Meedt E; Hiergeist A; Gessner A; Dettmer K; Liebisch G; Ghimire S; Poeck H; Edinger M; Wolff D; Herr W; Holler E; Weber D
Clin Infect Dis; 2022 Mar; 74(4):614-621. PubMed ID: 34043764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
